Citations 441
IPSS-Molecular but Not Individual Mutations Predicts Outcomes of Patients with Myelodysplastic Syndrome (MDS) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): A Mayo Clinic Cohort
Mohty, Razan , Vanegas, Yenny Moreno , Hochwald, Alexander , Kharfan‐Dabaja, Mohamed A. , Khera, Nandita , Litzow, Mark R. , Mangaonkar, Abhishek A. , Palmer, Jeanne , Sproat, Lisa Z., Viswanatha, David S., Foran, James M. , Heckman, Michael G. , Alkhateeb, Hassan B. , Hogan, William J. , Ketterling, Rhett P. , Murthy, Hemant S. , Shah, Meera
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4863-4864
Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy
Johnson, Isla McKerrow , Ilyas, Rimal, Al‐Kali, Aref , Begna, Kebede H. , Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew , Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3233-3234
Characteristics and Outcomes of Patients with BCOR Mutated Myeloid Neoplasms
Barua, Amit , Yıkılmaz, Aysun Şentürk , He, Rong , Viswanatha, David S., Katamesh, Bahga , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Litzow, Mark R. , Begna, Kebede H. , Tefferi, Ayalew , Al‐Kali, Aref , Baranwal, Anmol , Shah, Meera , Badar, Talha , Hogan, William J. , Alkhateeb, Hassan B.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3235-3236
Determinants of Survival and Retrospective Comparisons in 183 Clinical Trial Patients with Myelofibrosis Treated with Ruxolitinib, Fedratinib, Momelotinib, or BMS-911543 JAK2 Inhibitor between 2007 and 2013
Gangat, Naseema , Begna, Kebede H. , Al‐Kali, Aref , Litzow, Mark R. , Pardanani, Animesh , Tefferi, Ayalew , Hogan, William J.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3945-3946
Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy
Capellini, Alexandra, Etra, Aaron , Choe, Hannah , DeFilipp, Zachariah , Ayuk, Francis, Baez, Janna , Gandhi, Isha , Kasikis, Stelios, Gleich, Sigrun, Hoepting, Matthias, Kapoor, Urvi , Kowalyk, Steven, Langston, Amelia , Morales, George , Özbek, Umut , Roesler, Wolf, Spyrou, Nikolaos , Young, Rachel , Chen, Yi‐Bin , Ferrara, James L.M. , Alousi, Amin Majid , Malki, Monzr M. Al , Hogan, William J. , Kitko, Carrie L. , Hexner, Elizabeth O. , Kwon, Deukwoo , Mielcarek, Marco B. , Qayed, Muna , Reshef, Ran , Levine, John E.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1867-1869
Predictors of Response to Venetoclax Plus Hypomethylating Agent Therapy and Survival in Blast-Phase Myeloproliferative Neoplasm
Gangat, Naseema , Ilyas, Rimal, Begna, Kebede H. , Al‐Kali, Aref , Patnaik, Mrinal M. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Elliott, Michelle A. , Foran, James M. , Palmer, Jeanne , Hanson, Curtis A. , Pardanani, Animesh , Tefferi, Ayalew , McCullough, Kristen , Hogan, William J. , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9675-9676
Clinical and Genetic Characteristics of STAG2 Mutations in Myeloid Neoplasms
Katamesh, Bahga , Nanaa, Ahmad , He, Rong , Viswanatha, David S., Nguyen, Phuong L., Bessonen, Kurt, Gangat, Naseema , Begna, Kebede H. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Litzow, Mark R. , Foran, James M. , Al‐Kali, Aref , Greipp, Patricia T. , Hogan, William J. , Shah, Meera , Yi, Cecilia Arana , Badar, Talha , Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12353-12354
Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome
Pardanani, Animesh , Tefferi, Ayalew , Singh, Amritpal , Al‐Kali, Aref , Patnaik, Mrinal M. , Begna, Kebede, Elliott, Michelle A. , Khera, Nandita , Palmer, Jeanne , Gangat, Naseema , Kelemen, Katalin, Reichard, Kaaren K. , Hogan, William J. , Orazi, Attilio , Chen, Dong
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6872-6873
TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799
Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy
Ilyas, Rimal, Johnson, Isla McKerrow , Al‐Kali, Aref , Begna, Kebede, Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew, Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera , Tefferi, Ayalew
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1286-1287